The European Commission (EC) has granted marketing authorisation under exceptional circumstances for InflaRx’s Gohibic ...

导读肺挫伤是指胸部创伤后对肺实质造成的直接或间接的损伤，肺挫伤后血液和其他体液在肺组织内积聚，过多的液体使通气/血流比失衡，从而导致缺氧。肺挫伤是引起急性肺损伤(acute lung injury, ALI)、急性呼吸窘迫综合征(acute ...

InflaRx N.V. IFRX shares gained 7.7% on Wednesday following the European Commission's (EC) approval of marketing ...

One of the most severe manifestations of COVID-19 is Acute Respiratory Distress Syndrome (ARDS), a life-threatening condition in which the lungs can’t provide enough oxygen to the body’s vital ...

InflaRx receives European marketing authorization for Gohibicto treat of SARS-CoV-2-induced acute respiratory distress syndrome: Jena, Germany Friday, January 17, 2025, 11:00 Hrs ...

InflaRx (IFRX) announced that the European Commission has granted marketing authorization under exceptional circumstances for Gohibic for the ...

Gen1E-1124 is under clinical development by GEn1E Lifesciences and currently in Phase I for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome.

Study finds cardiovascular events in pregnancy significantly increase risks for preterm birth and SGA infants in autoimmune ...

CK-0802 is under clinical development by Cellenkos and currently in Phase I for Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome.

Considering taking supplements to treat acute respiratory distress syndrome ards? Below is a list of common natural remedies used to treat or reduce the symptoms of acute respiratory distress ...